Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. (Q37227424): Difference between revisions

From Wikidata

Jump to navigation Jump to search

Browse history interactively

← Older editNewer edit →

Revision as of 23:01, 14 April 2019 (restore) Daniel Mietchen (talk | contribs) 31,685,755 edits ‎Added reference to claim: author (P50): Kaj Blennow (Q28321550), #quickstatements; batch #10979 by User:Daniel Mietchen Tag: QuickStatements [1.3] ← Older edit		Revision as of 23:01, 14 April 2019 (restore) undo Daniel Mietchen (talk | contribs) 31,685,755 edits ‎Removed claim: author name string (P2093): Kaj Blennow, #quickstatements; batch #10979 by User:Daniel Mietchen Tag: QuickStatements [1.3] Newer edit →
Property / author name string
	Kaj Blennow
Property / author name string: Kaj Blennow / rank
	Normal rank
Property / author name string: Kaj Blennow / qualifier
	series ordinal: 7
Property / author name string: Kaj Blennow / reference
	stated in: Europe PubMed Central PMC publication ID: 2696350 retrieved: 19 August 2017 Timestamp +2017-08-19T00:00:00Z Timezone +00:00 Calendar Gregorian Precision 1 day Before 0 After 0

---

Revision as of 23:01, 14 April 2019

scientific article published on April 2009

Language	Label	Description	Also known as
English	Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.	scientific article published on April 2009

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

title

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

main subject

biomarker

0 references

Alzheimer's Disease Neuroimaging Initiative

0 references

neuroimaging

0 references

Alzheimer's disease

0 references

cerebrospinal fluid

0 references

author

Alzheimer's Disease Neuroimaging Initiative

series ordinal

16

object named as

Alzheimer's Disease Neuroimaging Initiative

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

Malgorzata Knapik-Czajka

object named as

Malgorzata Knapik-Czajka

series ordinal

3

0 references

Kaj Blennow

series ordinal

7

object named as

Kaj Blennow

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

author name string

Leslie M Shaw

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

Hugo Vanderstichele

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

Christopher M Clark

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

Paul S Aisen

series ordinal

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

Ronald C Petersen

series ordinal

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

Holly Soares

series ordinal

8

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

Adam Simon

series ordinal

9

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

Piotr Lewczuk

series ordinal

10

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

Robert Dean

series ordinal

11

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

Eric Siemers

series ordinal

12

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

William Potter

series ordinal

13

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

Virginia M-Y Lee

series ordinal

14

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

John Q Trojanowski

series ordinal

15

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

publication date

1 April 2009

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

published in

Annals of Neurology

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

volume

65

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

issue

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

page(s)

403-413

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

cites work

Commentary on "Optimal design of clinical trials for drugs designed to slow the course of Alzheimer's disease." Biochemical biomarkers of late-life dementia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

6 September 2017

Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

6 September 2017

CSF biomarkers in frontotemporal lobar degeneration with known pathology

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

6 September 2017

CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

6 September 2017

Biomarkers for early detection of Alzheimer pathology

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

6 September 2017

Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

6 September 2017

Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI).

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

6 September 2017

Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

6 September 2017

Cerebrospinal fluid beta-amyloid 1-42 concentration may predict cognitive decline in older women

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

6 September 2017

Frontotemporal dementia: clinicopathological correlations

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

6 September 2017

The role of biomarkers in clinical trials for Alzheimer disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

6 September 2017

Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

6 September 2017

Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

6 September 2017

CSF markers for incipient Alzheimer's disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

6 September 2017

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

6 September 2017

Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

14 September 2017

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

14 September 2017

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

14 September 2017

Diagnostic accuracy of ELISA and xMAP technology for analysis of amyloid beta(42) and tau proteins.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

26 June 2018

ApoE, Alzheimer's disease, and recovery from brain stress

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

26 June 2018

CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

3 September 2018

Cerebrospinal fluid biomarkers predict decline in subjective cognitive function over 3 years in healthy elderly.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

3 September 2018

Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

3 September 2018

Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

3 September 2018

Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

3 September 2018

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

3 September 2018

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2696350

retrieved

3 September 2018

Identifiers

DOI

10.1002/ANA.21610

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

PMC publication ID

2696350

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

PubMed publication ID

19296504

1 reference

stated in

Europe PubMed Central

PMC publication ID

2696350

retrieved

19 August 2017

ResearchGate publication ID

24210461

0 references

 

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37227424&oldid=914053472"